- Home
- CHEB vs RDIB Comparison
CHEB vs RDIB Comparison
Compare CHEB & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- RDIB
- Stock Information
- Founded
- CHEB 2024
- RDIB 1937
- Country
- CHEB Singapore
- RDIB United States
- Employees
- CHEB N/A
- RDIB N/A
- Industry
- CHEB
- RDIB Movies/Entertainment
- Sector
- CHEB
- RDIB Consumer Discretionary
- Exchange
- CHEB NYSE
- RDIB Nasdaq
- Market Cap
- CHEB 122.8M
- RDIB 140.2M
- IPO Year
- CHEB 2024
- RDIB N/A
- Fundamental
- Price
- CHEB $7.92
- RDIB $10.55
- Analyst Decision
- CHEB
- RDIB
- Analyst Count
- CHEB 0
- RDIB 0
- Target Price
- CHEB N/A
- RDIB N/A
- AVG Volume (30 Days)
- CHEB 24.6K
- RDIB 6.0K
- Earning Date
- CHEB 01-01-0001
- RDIB 06-06-2025
- Dividend Yield
- CHEB N/A
- RDIB N/A
- EPS Growth
- CHEB N/A
- RDIB N/A
- EPS
- CHEB N/A
- RDIB N/A
- Revenue
- CHEB N/A
- RDIB $205,644,000.00
- Revenue This Year
- CHEB N/A
- RDIB $9.74
- Revenue Next Year
- CHEB N/A
- RDIB $6.39
- P/E Ratio
- CHEB N/A
- RDIB N/A
- Revenue Growth
- CHEB N/A
- RDIB N/A
- 52 Week Low
- CHEB $6.09
- RDIB $5.78
- 52 Week High
- CHEB $13.70
- RDIB $21.34
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- RDIB 51.21
- Support Level
- CHEB N/A
- RDIB $9.30
- Resistance Level
- CHEB N/A
- RDIB $11.35
- Average True Range (ATR)
- CHEB 0.00
- RDIB 1.09
- MACD
- CHEB 0.00
- RDIB -0.14
- Stochastic Oscillator
- CHEB 0.00
- RDIB 27.23
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.